HilleVax, Inc.
NASDAQ:HLVX
1.88 (USD) • At close April 28, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 2.156 | 2.252 | 0.003 | 0 | 0 |
| Gross Profit
| 0 | -2.156 | -2.252 | -0.003 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 78.172 | 106.683 | 45.908 | 10.014 | 0 | 0 |
| General & Administrative Expenses
| 28.787 | 26.662 | 16.705 | 5.756 | 1.295 | 0.633 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0.632 |
| SG&A
| 28.787 | 26.662 | 16.705 | 5.756 | 1.295 | 0.633 |
| Other Expenses
| 48.332 | 0 | -94.696 | -20.227 | -0.779 | 0 |
| Operating Expenses
| 155.291 | 133.345 | 62.613 | 15.77 | 1.295 | 0.633 |
| Operating Income
| -155.291 | -133.345 | -65.113 | -53.426 | -1.295 | -0.633 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 8.024 | 9.779 | -94.696 | -48.982 | -0.808 | -0.04 |
| Income Before Tax
| -147.267 | -123.566 | -159.809 | -102.408 | -2.103 | -0.673 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 97.196 | -17.383 | 0.029 | -0.001 |
| Net Income
| -147.267 | -123.566 | -257.005 | -85.025 | -2.132 | -0.673 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -3 | -3.04 | -6.83 | -2.82 | -0.071 | -0.022 |
| EPS Diluted
| -3 | -3.04 | -6.83 | -2.82 | -0.071 | -0.022 |
| EBITDA
| -155.291 | -132.466 | -65.113 | -99.561 | -2.074 | -0.031 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |